Antibody Drug Conjugates Market Size, Share & Trends Report

Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer), By Technology ({Type-Cleavable, Non-cleavable}), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-2-68038-741-4
  • Number of Pages: 135
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Market segmentation

  • Antibody drug Conjugates Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Blood Cancer
      • Leukemia
      • Lymphoma
      • Multiple Myeloma
    • Breast Cancer
    • Urothelial Cancer & Bladder Cancer
    • Other Cancer
  • Antibody drug Conjugates Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • Technology Type
      • Cleavable Linker
      • Non- cleavable Linker
      • Linkerless
    • Linker Technology Type
      • VC
      • Sulfo-SPDB
      • VA
      • Hydrazone
      • Others
    • Payload Technology
      • MMAE
      • MMAF
      • DM4
      • Camptothecin
      • Others
  • Antibody drug Conjugates Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Antibody drug Conjugates Market, by Application
        • Blood Cancer
          • Leukemia
          • Lymphoma
          • Multiple Myeloma
        • Breast Cancer
        • Urothelial Cancer & Bladder Cancer
        • Other Cancer
      • North America Antibody drug Conjugates Market, by Technology
        • Technology Type
          • Cleavable Linker
          • Non- cleavable Linker
          • Linkerless
        • Linker Technology Type
          • VC
          • Sulfo-SPDB
          • VA
          • Hydrazone
          • Others
        • Payload Technology
          • MMAE
          • MMAF
          • DM4
          • Camptothecin
          • Others
      • U.S.
        • U.S. Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • U.S. Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Canada
        • Canada Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Canada Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
    • Europe
      • Europe Antibody drug Conjugates Market, by Application
        • Blood Cancer
          • Leukemia
          • Lymphoma
          • Multiple Myeloma
        • Breast Cancer
        • Urothelial Cancer & Bladder Cancer
        • Other Cancer
      • Europe Antibody drug Conjugates Market, by Technology
        • Technology Type
          • Cleavable Linker
          • Non- cleavable Linker
          • Linkerless
        • Linker Technology Type
          • VC
          • Sulfo-SPDB
          • VA
          • Hydrazone
          • Others
        • Payload Technology
          • MMAE
          • MMAF
          • DM4
          • Camptothecin
          • Others
      • UK
        • UK Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • UK Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Germany
        • Germany Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Germany Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • France
        • France Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • France Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Italy
        • Italy Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Italy Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Spain
        • Spain Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Spain Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Denmark
        • Denmark Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Denmark Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Sweden
        • Sweden Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Sweden Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Norway
        • Norway Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Norway Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
    • Asia Pacific
      • Asia Pacific Antibody drug Conjugates Market, by Application
        • Blood Cancer
          • Leukemia
          • Lymphoma
          • Multiple Myeloma
        • Breast Cancer
        • Urothelial Cancer & Bladder Cancer
        • Other Cancer
      • Asia Pacific Antibody drug Conjugates Market, by Technology
        • Technology Type
          • Cleavable Linker
          • Non- cleavable Linker
          • Linkerless
        • Linker Technology Type
          • VC
          • Sulfo-SPDB
          • VA
          • Hydrazone
          • Others
        • Payload Technology
          • MMAE
          • MMAF
          • DM4
          • Camptothecin
          • Others
      • South Korea
        • South Korea Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • South Korea Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Japan
        • Japan Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Japan Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • China
        • China Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • China Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • India
        • India Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • India Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Australia
        • Australia Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Australia Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Thailand
        • Thailand Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Thailand Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
    • Latin America
      • Latin America Antibody drug Conjugates Market, by Application
        • Blood Cancer
          • Leukemia
          • Lymphoma
          • Multiple Myeloma
        • Breast Cancer
        • Urothelial Cancer & Bladder Cancer
        • Other Cancer
      • Latin America Antibody drug Conjugates Market, by Technology
        • Technology Type
          • Cleavable Linker
          • Non- cleavable Linker
          • Linkerless
        • Linker Technology Type
          • VC
          • Sulfo-SPDB
          • VA
          • Hydrazone
          • Others
        • Payload Technology
          • MMAE
          • MMAF
          • DM4
          • Camptothecin
          • Others
      • Argentina
        • Argentina Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Argentina Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Brazil
        • Brazil Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Brazil Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Mexico
        • Mexico Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Mexico Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
    •  MEA
      • MEA Antibody drug Conjugates Market, by Application
        • Blood Cancer
          • Leukemia
          • Lymphoma
          • Multiple Myeloma
        • Breast Cancer
        • Urothelial Cancer & Bladder Cancer
        • Other Cancer
      • MEA Antibody drug Conjugates Market, by Technology
        • Technology Type
          • Cleavable Linker
          • Non- cleavable Linker
          • Linkerless
        • Linker Technology Type
          • VC
          • Sulfo-SPDB
          • VA
          • Hydrazone
          • Others
        • Payload Technology
          • MMAE
          • MMAF
          • DM4
          • Camptothecin
          • Others
      • South Africa
        • South Africa Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • South Africa Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Saudi Arabia
        • Saudi Arabia Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Saudi Arabia Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • UAE
        • UAE Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • UAE Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others
      • Kuwait
        • Kuwait Antibody drug Conjugates Market, by Application
          • Blood Cancer
            • Leukemia
            • Lymphoma
            • Multiple Myeloma
          • Breast Cancer
          • Urothelial Cancer & Bladder Cancer
          • Other Cancer
        • Kuwait Antibody drug Conjugates Market, by Technology
          • Technology Type
            • Cleavable Linker
            • Non- cleavable Linker
            • Linkerless
          • Linker Technology Type
            • VC
            • Sulfo-SPDB
            • VA
            • Hydrazone
            • Others
          • Payload Technology
            • MMAE
            • MMAF
            • DM4
            • Camptothecin
            • Others

Antibody Drug Conjugates Market Dynamics

Driver: Growing Geriatric Population

The growing geriatric population globally is creating a high risk of developing numerous diseases including neurological disorders, cancer, cardiovascular diseases obesity, and diabetes. Aging is influenced by numerous environmental & genetic factors and is characterized as the single most substantial risk factor for cancer. Based on WHO, life expectancy is now exceeding 80 years in most developed economies. Moreover,according to a the UN report, in 2020, there were about 727 million people aged 65 years & above globally.The number of individuals aged 80 years and above is projected to double by 2050, reaching more than 1.5 billion worldwide. According to US National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) Database, 38% of women and 43% of men are projected to develop cancer throughout their lifetime. In addition, nearly two-thirds of all new cancer cases are diagnosed in people aged 65 years and above, showing that aging can make people more vulnerable to cancer. This significant prevalence is anticipated to propel the antibody drug conjugates market.

Driver: Increasing Incidence and Prevalence of Cancer

The growing prevalence of cancer globally is one of the crucial factors to drive market growth in the coming years.  Aging is the most common reason that upsurges the risk of cancer. Furthermore, improper diet, alcohol consumption, and lack of exercise can cause cancer. However, Cancer Research UK estimates that GP visits for cancer cases can be reduced by ~40% if a healthier lifestyle is adopted, including maintaining a healthier weight, being more physically active,  cessation of smoking,  adopting regular eating & drinking practices, and implementing sun safety practices. The overall increase in the prevalence of cancer is expected to boost the number of patients undergoing treatment, which increases the need for early diagnosis & treatment. This increase cancer incidence is likely to increase the demand for antibody drug conjugates (ADCs) globally.

Restraint: Stringent Reimbursement Policies for ADCS

ADCS drug is typically high in cost. Reimbursement policies play a substantial role in most developed economies. The higher cost of the ADCS is anticipated to impede reimbursement coverage. Furthermore, the lack of availability of reimbursement policies in developing economies, such as Singapore, India, Indonesia, and Malaysia, is further projected to restrict the market.

What Does This Report Include?

This section will provide insights into the contents included in this antibody drug conjugates market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Antibody drug conjugates market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Antibody drug conjugates market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon